Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic calcipotriol-betamethasone ointment versus Daivobet and vehicle in chronic stable plaque psoriasis
2016-001568-12Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone, calcipotriol and betamethasone dipropionate in plaque psoriasis (3 arms), sponsored by Dermapharm. Primary endpoint: Mean percent change from baseline in modified PASI score at week 4. Started Aug 2016; status: completed.
02
Drugs
calcipotriol + betamethasonecalcipotriolbetamethasone dipropionate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2016-001568-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001568-12.